Kai Immonen

823 total citations
9 papers, 147 citations indexed

About

Kai Immonen is a scholar working on Molecular Biology, Surgery and Rheumatology. According to data from OpenAlex, Kai Immonen has authored 9 papers receiving a total of 147 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Rheumatology. Recurrent topics in Kai Immonen's work include Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Kai Immonen is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Kai Immonen collaborates with scholars based in Finland. Kai Immonen's co-authors include Markku Hakala, Hannu Kautiainen, Carola Grönhagen‐Riska, Patrik Finne, Tom Pettersson, Timo Klaukka, Jari Satta, Tatu Juvonen, Risto Pokela and Esa Läärä and has published in prestigious journals such as Scandinavian Journal of Rheumatology, Amyloid and JCR Journal of Clinical Rheumatology.

In The Last Decade

Kai Immonen

9 papers receiving 140 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kai Immonen Finland	8	70	58	36	34	33	9	147
Lenka Bauerová Czechia	7	66 0.9×	41 0.7×	8 0.2×	41 1.2×	24 0.7×	11	141
Nilüfer Alpay Kanıtez Türkiye	7	37 0.5×	57 1.0×	11 0.3×	23 0.7×	9 0.3×	23	159
Marco Waleboer Netherlands	4	46 0.7×	33 0.6×	66 1.8×	6 0.2×	18 0.5×	6	178
Fiammetta Ravaglia Italy	7	95 1.4×	15 0.3×	19 0.5×	124 3.6×	50 1.5×	15	228
Mervat I. Abd Elazeem Egypt	8	17 0.2×	99 1.7×	36 1.0×	11 0.3×	15 0.5×	17	143
Franco Bergesio Italy	9	150 2.1×	15 0.3×	23 0.6×	104 3.1×	21 0.6×	26	237
Sophie Cereja France	3	88 1.3×	94 1.6×	85 2.4×	10 0.3×	46 1.4×	8	244
Iwona Kobielusz‐Gembala Poland	5	23 0.3×	23 0.4×	6 0.2×	25 0.7×	42 1.3×	9	143
Kah Mean Thong Malaysia	6	61 0.9×	34 0.6×	9 0.3×	49 1.4×	9 0.3×	12	152
Ivan Krečak Croatia	7	69 1.0×	70 1.2×	78 2.2×	9 0.3×	18 0.5×	55	185

Countries citing papers authored by Kai Immonen

Since Specialization

Citations

This map shows the geographic impact of Kai Immonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Immonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Immonen more than expected).

Fields of papers citing papers by Kai Immonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Immonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Immonen. The network helps show where Kai Immonen may publish in the future.

Co-authorship network of co-authors of Kai Immonen

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Immonen. A scholar is included among the top collaborators of Kai Immonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Immonen. Kai Immonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Valleala, Heikki, et al.. (2015). Long-Term Real-Life Experience With Rituximab in Adult Finnish Patients With Rheumatoid Arthritis Refractory or With Contraindication to Anti–Tumor Necrosis Factor Drugs. JCR Journal of Clinical Rheumatology. 21(1). 24–30. 10 indexed citations

2.

Immonen, Kai, Patrik Finne, Carola Grönhagen‐Riska, et al.. (2011). A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases – data from nationwide registries in Finland. Amyloid. 18(1). 25–28. 41 indexed citations

3.

Immonen, Kai, Tom Pettersson, Patrik Finne, et al.. (2011). Decline in the incidence of renal failure due to amyloidosis associated with inflammatory rheumatic diseases. Amyloid. 18(sup1). 229–230. 3 indexed citations

4.

Immonen, Kai, et al.. (2010). More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases. Scandinavian Journal of Rheumatology. 39(6). 461–465. 10 indexed citations

5.

Virkki, Liisa, Yrjö T. Konttinen, Ritva Peltomaa, et al.. (2009). Cost-effectiveness of infliximab in the treatment of rheumatoid arthritis in clinical practice.. PubMed. 26(6). 1059–66. 14 indexed citations

6.

Immonen, Kai, Patrik Finne, Markku Hakala, et al.. (2008). No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases -- data from the Finnish national registry for kidney diseases.. PubMed. 35(7). 1334–8. 29 indexed citations

7.

Immonen, Kai, et al.. (2008). Longterm outcome of amyloidosis associated with juvenile idiopathic arthritis.. PubMed. 35(5). 907–12. 19 indexed citations

8.

Satta, Jari, et al.. (1997). The rupture type determines the outcome for ruptured abdominal aortic aneurysm patients.. PubMed. 86(1). 24–9. 9 indexed citations

9.

Satta, Jari, et al.. (1996). Outcome of elective infrarenal abdominal aortic aneurysm repair--an analysis of 174 consecutive patients.. PubMed. 85(3). 231–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact